Having a close relative who has had a bout with shingles
puts people at a heightened risk of suffering a similar outbreak, a new study
finds.
A herpes virus called varicella zoster causes shingles and
chickenpox. Since nearly everyone in the United States over age 25 has been exposed
to the chickenpox virus, much of the population is at risk for shingles, which
strikes in middle age and beyond. After causing a chickenpox infection, the
virus lies dormant in nerves for decades. The virus can resurface as the nasty
skin rash, blisters, itching and pain that mark a case of shingles. Some
symptoms can last for weeks or months.
But only about one in five people exposed to chickenpox ultimately
get shingles, says Stephen Tyring, a virologist and dermatologist at the
University of Texas Health Science Center in Houston. Scientists suspect the immune system
somehow keeps the virus bottled up in nerves better in some people than in
others. People with compromised immune systems face a greater-than-average risk
of shingles.
To test for a familial link, Tyring and his colleagues
identified 504 people who had shingles and matched them with 523 volunteers who
hadn’t. Everyone was over age 25; most fell between 46 and 75 years of age. The
groups were matched overall for age, gender and race.
When the researchers compared family histories between the
groups, they found that roughly 39 percent of the shingles patients had a close
relative who also had had the disease. Only 11 percent of the controls did,
they report in the May Archives of
Dermatology. The researchers defined a close relative as a parent, child,
sibling, uncle, aunt or first cousin.
A vaccine for chickenpox introduced in the United States in 1996 will probably
knock down the risk of shingles for future generations, says Tyring. Meanwhile,
a vaccine against shingles became available in 2006.
“Those with family members who have had shingles should
consider being the first in line to be vaccinated,” he says. Insurance coverage
for the shingles vaccine typically starts at age 60, but studies are under way
to see whether this should be expanded to include 50-somethings, Tyring says.
Many scientists suspect that good immune system surveillance
keeps the virus under wraps and locked indefinitely in nerve tissue in most
people. In 2002, Finnish researchers reported evidence suggesting that having a
specific variant form of a gene that encodes an immune protein called interleukin-10
might contribute to a person’s susceptibility to shingles. Interkeukin-10 inhibits
inflammation in the body, but its role in shingles remains unclear.
The new study may spur more research aimed at sorting out this
and other potential biomechanisms that could underlie susceptibility to
shingles, Tyring says.
Found in: Biomedicine and Body & Brain